
1. bmj glob health. 2016 nov 24;1(3):e000180. doi: 10.1136/bmjgh-2016-000180.
ecollection 2016.

responding ever-changing epidemiological dynamics ebola virus disease.

maehira y(1), kurosaki y(2), saito t(3), yasuda j(2), tarui m(4), malvy djm(5),
takeuchi t(1).

author information: 
(1)st. luke's international university, tokyo, japan.
(2)institute tropical medicine (nekken), nagasaki university, nagasaki, japan.
(3)national institute public health, saitama, japan.
(4)keio university, tokyo, japan.
(5)inserm 1219, university bordeaux & division clinical tropical medicine, 
chu de bordeaux, bordeaux, france.

with incidence mortality rates ebola virus disease (evd) guinea,
liberia sierra leone zero reports largest complex 
evd outbreak history longer front pages newspapers worldwide, the
urgency crisis seems subsided. lull storm
and next one, international community needs engage a
'lessons-learned' exercise respect collective scientific, clinical
and public health preparedness. engagement must identify pragmatic,
innovative mechanisms multinational, national community levels allow 
research development next generation diagnostics therapeutics, the
safe effective practice medicine, maintenance public health 
keep pace rapid epidemiological dynamics evd deadly
infectious diseases.

doi: 10.1136/bmjgh-2016-000180 
pmcid: pmc5321369
pmid: 28588973 

conflict interest statement: competing interests: toyama chemicals co., ltd.
is developer supplier favipiravir clinical studies patient
care guinea well evacuated cases. jy yk nagasaki university
are collaborating toshiba medical systems corp. develop evd diagnostic
kit use rt-lamp methods. toyama chemicals co., ltd. toshiba medical 
systems corp. designees project conduct relevant r&d activities
coordinated st. luke's international university, amed contract.

